相关实验视频

Updated: Jun 27, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K

使用microRNA表达的集体基础分类识别了乳腺癌患者的子组,其转移的长期风险超低

Ines Block1, Mark Burton1,2,3, Kristina P Sørensen1

  • 1Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Cancer medicine
|April 27, 2024
PubMed
概括

初级瘤中微RNA的差异表达可以识别惰的淋巴结阴性 (LNN) 乳腺癌 (BC) 患者. 这可能有助于避免不必要的全身治疗低风险的BC患者.

关键词:
低风险的乳腺癌.淋巴结阴性 淋巴结阴性基于microRNA的复发预测过度处理减少过度处理系统地未经治疗.

更多相关视频

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

6.8K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.0K

相关概念视频

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K